FDA Makes an Announcement - Good News for Vaping
In what is being viewed as a victory for the vaping industry, today the Food and Drug Administration (FDA) announced a new plan for tobacco and nicotine regulation. Along with this new regulation plan, the FDA also delayed the Pre-Market Tobacco Application (PMTA) registration date to August 8, 2022.
Tobacco use continues at an alarming rate and causes more than 480,000 deaths each year in the United States alone. The FDA’s new approach focuses on nicotine and addiction to it. The agency plans to demonstrate a greater awareness that nicotine, although addictive, is delivered through products that pose risk to users and is increased when delivered through combustible cigarettes.
“The overwhelming amount of death and disease attributable to tobacco is caused by addiction to cigarettes – the only legal consumer product that, when used as intended, will kill half of all long-term users,” said FDA Commissioner Scott Gottlieb, M.D. “Unless we change course, 5.6 million young people alive today will die prematurely later in life from tobacco use. Envisioning a world where cigarettes would no longer create or sustain addiction, and where adults who still need or want nicotine could get it from alternative and less harmful sources, needs to be the cornerstone of our efforts – and we believe it’s vital that we pursue this common ground.”
Although the announcement still needs to be dissected, interpreted and explained by lawyers, it offers a feeling of relief for many in the vaping industry. The FDA’s prior announcement left many questions and would have forced owners to make serious decisions, such as changing business models or ceasing operations.